DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Saad F, Gleason DM, Murray R. et al.
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
J Natl Cancer Inst 2002;
94: 1458-1468
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.